Treatment of infertility by intrauterine inseminatio
Not Applicable
Completed
- Registration Number
- CTRI/2012/05/002682
- Lead Sponsor
- Employee state insurance post graduate institute of medicine and researchBASAIDARAPUR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
2.Primary or Secondary infertility
3.BMI â?? 18 â?? 30 kg/ m2
4.Regular menstrual cycles (25-35 days)
5.Normal basal FSH( <10m IU/l)
6.Patients with unexplained infertility
7.Mild male factor
8.Patency of both or either one of the tubes (HSG/Laprohysteroscopy).
Exclusion Criteria
2.Antral follicle count 4
3.Patients with uterine anomalies.
4.Patients with PCOS (as per Rotterdam criteria)
5.Patients with endometriosis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.LH surge and premature lutenisation ( S.LH 20 mIU/ml, S.Prog 1ng/ml)13 <br/ ><br>2.Pregnancy rate <br/ ><br>Timepoint: 1.LH surge and premature lutenisation ( S.LH 20 mIU/ml, S.Prog 1ng/ml)13 <br/ ><br>2.Pregnancy rate <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.Number of oocytes 18mm on day of trigger <br/ ><br>2.Estradiol levels on the day of trigger <br/ ><br>3.Duration of use of GnRH antagonist <br/ ><br>4.Amount of gonadotropins used <br/ ><br>5.Incidence and severity of OHSS <br/ ><br>6.Impact of GnRH antagonists on endometrial thickness. <br/ ><br>7.Total duration of therapy <br/ ><br>Timepoint: one month